Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.06%238.21M | 9.63%1.03B | 20.56%290.69M | -5.57%243.45M | 18.84%281.16M | 20.46%248.27M | -6.49%941.63M | -3.92%241.12M | 17.36%257.81M | -13.09%236.59M |
| Cost of revenue | -2.76%189.03M | 7.82%810M | 21.09%225.85M | -5.35%198.31M | 14.14%218.9M | 18.96%194.39M | 0.61%751.22M | -3.94%186.52M | 31.66%209.51M | -8.70%191.78M |
| Gross profit | -8.73%49.18M | 16.73%222.27M | 18.75%64.84M | -6.55%45.14M | 38.94%62.26M | 26.22%53.88M | -26.85%190.41M | -3.85%54.61M | -20.23%48.3M | -27.92%44.81M |
| Operating expense | -3.91%20.49M | 7.04%83.05M | 43.59%26.27M | 1.79%18.68M | 0.82%26.35M | -1.41%21.32M | -0.88%77.59M | -7.66%18.3M | 22.72%18.35M | 115.60%26.14M |
| Selling and administrative expenses | -3.91%20.49M | 2.57%79.78M | 43.59%26.27M | 1.79%18.68M | 0.82%26.35M | -1.41%21.32M | -4.99%77.78M | -21.81%18.3M | 22.72%18.35M | 115.60%26.14M |
| -General and administrative expense | -3.91%20.49M | 2.57%79.78M | 43.59%26.27M | 1.79%18.68M | 0.82%26.35M | -1.41%21.32M | -4.99%77.78M | -21.81%18.3M | 22.72%18.35M | 115.60%26.14M |
| Other operating expenses | ---- | 1,774.99%3.27M | ---- | ---- | ---- | ---- | 94.56%-195.23K | ---- | ---- | ---- |
| Operating profit | -11.89%28.69M | 23.40%139.22M | 6.23%38.57M | -11.66%26.46M | 92.29%35.91M | 54.58%32.56M | -38.02%112.82M | -1.81%36.31M | -34.31%29.95M | -62.69%18.67M |
| Net non-operating interest income (expenses) | -14.68%308K | -77.49%469.98K | 307.58%269K | -86.62%150K | -86.79%102K | -41.77%361K | 4,301.44%2.09M | -84.23%66K | 775.78%1.12M | 684.85%772K |
| Non-operating interest income | 29.36%1.52M | -11.53%4.09M | 198.80%1.49M | -30.64%1.15M | -35.09%999K | -17.31%1.18M | 44.18%4.63M | -40.54%500K | 63.19%1.66M | 84.09%1.54M |
| Non-operating interest expense | 48.89%1.21M | 42.69%3.62M | 182.26%1.23M | 86.22%1M | 16.95%897K | 1.62%814K | -19.68%2.54M | 2.72%434K | -39.53%537K | -20.76%767K |
| Net investment income | 112.85%4.73M | -54.55%2.22M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 9.78%4.59M | 73.25%4.18M | ||||||||
| Income from associates and other participating interests | 40.45%684K | 885.30%4.13M | 1,766.88%2.88M | 383.45%788K | -21.54%295K | 189.88%487K | -87.43%419.27K | -27.02%154K | 19.19%-278K | -87.49%376K |
| Special income (charges) | 207.71%5.38M | 115.09%1.75M | ||||||||
| Less:Impairment of capital assets | ---- | --0 | ---- | ---- | ---- | ---- | ---769.34K | ---- | ---- | ---- |
| Less:Other special charges | ---- | -449.44%-5.38M | ---- | ---- | ---- | ---- | -20.46%-979.37K | ---- | ---- | ---- |
| Less:Write off | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 545.84%6.52M | -24.88%1.69M | 85.76%5.97M | 66.85%7.26M | 9.19%5.99M | -72.58%1.01M | 50.18%2.25M | 133.37%3.22M | 69.84%4.35M | 56.69%5.48M |
| Income before tax | 5.18%36.2M | 27.42%160.21M | 19.99%47.69M | -1.39%34.66M | 67.13%42.29M | 34.79%34.42M | -35.53%125.73M | 10.13%39.75M | -26.69%35.15M | -55.14%25.31M |
| Income tax | 37.98%5.17M | 11.10%21.24M | 14.56%6.63M | -32.58%3.79M | 128.02%8.15M | -9.23%3.75M | -4.22%19.11M | 7.81%5.79M | 8.81%5.62M | 0.51%3.58M |
| Net income | 1.17%31.03M | 30.35%138.97M | 20.91%41.06M | 4.55%30.87M | 57.10%34.14M | 43.28%30.67M | -39.10%106.61M | 10.54%33.96M | -30.98%29.53M | -58.89%21.73M |
| Net income continuous operations | 1.17%31.03M | 30.35%138.97M | 20.91%41.06M | 4.55%30.87M | 57.10%34.14M | 43.28%30.67M | -39.10%106.61M | 10.54%33.96M | -30.98%29.53M | -58.89%21.73M |
| Noncontrolling interests | -23.06%4.7M | 2.75%20.99M | 7.55%5.48M | -28.76%3.84M | 17.05%5.11M | 15.73%6.11M | -25.02%20.42M | -9.70%5.1M | -5.33%5.39M | -31.24%4.36M |
| Net income attributable to the company | 7.20%26.33M | 36.89%117.99M | 23.27%35.58M | 11.98%27.03M | 67.17%29.03M | 52.31%24.56M | -41.70%86.19M | 15.09%28.86M | -34.91%24.14M | -62.66%17.37M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 7.20%26.33M | 36.89%117.99M | 23.27%35.58M | 11.98%27.03M | 67.17%29.03M | 52.31%24.56M | -41.70%86.19M | 15.09%28.86M | -34.91%24.14M | -62.66%17.37M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 7.31%0.0661 | 36.91%0.296 | 23.34%0.0893 | 11.88%0.0678 | 66.97%0.0728 | 52.10%0.0616 | -41.71%0.2162 | 15.10%0.0724 | -34.91%0.0606 | -62.58%0.0436 |
| Diluted earnings per share | 7.31%0.0661 | 36.91%0.296 | 23.34%0.0893 | 11.88%0.0678 | 66.97%0.0728 | 52.10%0.0616 | -41.71%0.2162 | 15.10%0.0724 | -34.91%0.0606 | -62.58%0.0436 |
| Dividend per share | 0 | 0.00%0.06 | 0 | 0.00%0.03 | 0.00%0.03 | 0 | 9.09%0.06 | 0 | 0.00%0.03 | 20.00%0.03 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.